Lyme Disease: A Rapidly Emerging Bacterial Infection in Need of New Diagnostics
This article was first published on Clinical Lab Products. Lyme disease is now the most common and fastest growing vector-borne illness in the Western world. A two-tiered antibody testing approach is currently used for clinical diagnosis, but suffers from several...
Q&A: An Insight Into COVID-19 Serology
During the course of the current coronavirus pandemic, we have all been aware of the urgent need for nucleic acid testing to identify people currently infected with SARS-CoV-2. The second form of testing needed are serological immunoassays, which can identify past...
A Q&A with David Flavell of Leukaemia Busters
In this blog, we speak with Dr. David Flavell about his scientific career, the legacy of Leukaemia Busters, and the recent impact that COVID-19 has had on his research. Tell me about your scientific background David. I was born in a seaside town called Southport in...
Designing for Differentiation: Why We Need Highly Specific Diagnostics for a COVID-19 Vaccine
Assessment of vaccine-induced immune responses in clinical trials will require highly specific diagnostic assays to ensure safety. This blog was originally published on Clinical Lab Manager. The Vaccine Race Vaccines are the most effective means of preventing...